NCT04522687
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Carcinoma, Squamous Cell
Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.
1,631 public trials
442 recruiting studies
Carcinoma, Squamous Cell trial results
Recruiting
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
NCT03975322
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
- Locations
-
- Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg Erlangen, Germany
Enrolling by Invitation
A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data
NCT07532928
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Deep Learning, +7 more
- Locations
-
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University Guangzhou, China
Enrolling by Invitation
The Importance of Mucosal Screening in the Prevention of Oral Cancer.
NCT07682883
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- Medical University of Warsaw Warsaw, Masovian Voivodeship, Poland
Enrolling by Invitation
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
NCT07218003
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- START Midwest Grand Rapids, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Enrolling by Invitation
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
NCT07618624
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
- Locations
-
- The First People's Hospital of Foshan Foshan, Guangdong, China
- Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou, Guangdong, China
- Guangzhou First People's Hospital Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Enrolling by Invitation
Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients
NCT07606638
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +11 more
- Locations
-
- Mayo Hospital, Lahore Lahore, Punjab Province, Pakistan
Enrolling by Invitation
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
NCT06885424
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- NYU Langone Medical Center New York, United States
Enrolling by Invitation
Infiltration Pattern of Locally Advanced ESCC
NCT07567716
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +18 more
- Locations
-
- Shanghai Chest Hospital Shanghai, China
Enrolling by Invitation
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
NCT07550972
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China